Physicians base their decisions to antagonize neuromuscular blocking drugs on the pharmacological forecast and a qualitative judgment of the adequacy of the breathing pattern, according to a study published in the Sept. 2011 issue of Anesthesia & Analgesia.
In anesthesia practice, inadequate antagonism of neuromuscular blocking drugs may lead to frequent prevalence of residual neuromuscular block that is associated with morbidity and death.
The researchers conducted sequential surveys among 108 clinical anesthesiologists to elicit the rules of thumb that support their decisions to antagonize neuromuscular blocking drugs. The survey was intended to provide a measurement of the confidence physicians have in their own decisions compared with their peers' decisions.
The report found that clinicians judge themselves as better skilled at avoiding residual block than they do their colleagues, making them overconfident in their capacity to estimate the duration of action of intermediate-acting NMBD.
Related Articles on Anesthesia:
Somnia Anesthesia Blog Discusses Drug Shortage
Baxter International Sues Teva Over Indemnity Agreement in Hep C Case
The Medicare Bundled Payment Initiative: An Alert From Anesthesia Business Consultants
In anesthesia practice, inadequate antagonism of neuromuscular blocking drugs may lead to frequent prevalence of residual neuromuscular block that is associated with morbidity and death.
The researchers conducted sequential surveys among 108 clinical anesthesiologists to elicit the rules of thumb that support their decisions to antagonize neuromuscular blocking drugs. The survey was intended to provide a measurement of the confidence physicians have in their own decisions compared with their peers' decisions.
The report found that clinicians judge themselves as better skilled at avoiding residual block than they do their colleagues, making them overconfident in their capacity to estimate the duration of action of intermediate-acting NMBD.
Related Articles on Anesthesia:
Somnia Anesthesia Blog Discusses Drug Shortage
Baxter International Sues Teva Over Indemnity Agreement in Hep C Case
The Medicare Bundled Payment Initiative: An Alert From Anesthesia Business Consultants